Bruker Corporation (BRKR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $9.41B
Last updated: Nov 17, 2026 at 11:05 AM ET
Bruker Corporation (BRKR) Stock Forecast
Analysts expect Bruker (BRKR) to earn $2.14 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.54B. Of 13 analysts, 6 rate the stock Buy or Strong Buy, 6 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 6 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 13 ratings average 2.54, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 46% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 7.7% |
| Buy | 5 | 38.5% |
| Hold | 6 | 46.2% |
| Sell | 1 | 7.7% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 13
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 14.5% and revenue estimates rise 4.2%.
- Fiscal year ending Dec 31, 2026
- $2.14
- EPS consensus, revenue $3.54B
- Fiscal year ending Dec 31, 2027
- $2.45
- EPS consensus, revenue $3.69B
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.14 | $2.10 to $2.21 | 13 | $3.54B | $3.52B to $3.55B | 12 |
| Dec 31, 2027 | $2.45 | $2.36 to $2.71 | 13 | $3.69B | $3.65B to $3.74B | 12 |
Quarterly Estimates
The EPS consensus falls from $0.80 for the quarter ending Dec 31, 2026 to $0.44 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.80 | $0.74 to $0.96 | 14 | $1.03B | $969.17M to $1.08B | 14 |
| Mar 31, 2027 | $0.44 | $0.33 to $0.54 | 9 | $856.42M | $846.20M to $874.03M | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 8 upward and 3 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 6 | 2 |
| Quarter ending Mar 31, 2027 | 2 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.9% from $2.12.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.14 | $2.12 | $2.12 | $2.12 | $2.12 | +0.7% |
| Fiscal year ending Dec 31, 2027 | $2.45 | $2.40 | $2.41 | $2.39 | $2.41 | +1.9% |
| Quarter ending Mar 31, 2027 | $0.44 | $0.42 | $0.42 | $0.44 | $0.44 | +0.6% |
Frequently Asked Questions About BRKR
What is the BRKR stock forecast?
Consensus analyst estimates put Bruker's EPS at $2.14 for the fiscal year ending Dec 31, 2026, on revenue of $3.54B. The consensus rating from 13 analysts is Hold.
How do analysts rate BRKR stock?
Of 13 analysts covering Bruker, 1 rates it Strong Buy, 5 Buy, 6 Hold, 1 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from BRKR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.14, with estimates from $2.10 to $2.21 from 13 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.45, with estimates from $2.36 to $2.71 from 13 analysts.
What revenue do analysts expect from Bruker next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.54B, with estimates from $3.52B to $3.55B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.69B, with estimates from $3.65B to $3.74B.
How many analysts cover BRKR?
13 analysts rate Bruker stock, and 13 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
BRKR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts